The global autoinjectors market has witnessed significant growth over the years, owing to the rising demand for self-administration devices and the increasing prevalence of chronic diseases. To cater to this demand, manufacturers are focused on developing advanced autoinjectors that can improve patient outcomes and reduce the risk of errors. Some of the emerging technologies and innovations in the autoinjectors market are:
- Connected Autoinjectors: Connected autoinjectors are equipped with sensors and wireless technology that allow patients and healthcare providers to monitor drug delivery and patient adherence. These devices can send notifications to remind patients to take their medication, track usage, and provide real-time feedback on drug delivery. For instance, Kaleo’s Auvi-Q autoinjector is equipped with Bluetooth technology that connects to a mobile app, which can track medication usage, expiration dates, and provide refill reminders.
- Biologics-Compatible Autoinjectors: With the growing use of biologics in the treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis, there is a need for autoinjectors that can handle these high-viscosity drugs. Biologics-compatible autoinjectors are designed to reduce pain and discomfort during injection and ensure accurate drug delivery. For instance, BD’s NevoSi autoinjector is designed to deliver high-viscosity biologics with low injection force and features a hidden needle to minimize the fear of injection.
- Wearable Autoinjectors: Wearable autoinjectors are designed to provide patients with a convenient and discreet way to administer their medication. These devices can be worn on the body, such as on the arm or thigh, and can be programmed to deliver the medication at a specific time. For instance, Amgen’s Repatha SureClick autoinjector features a wearable device called Pushtronex, which delivers a single dose of medication at the push of a button.
- Needle-Free Autoinjectors: Needle-free autoinjectors are designed to eliminate the need for a needle during drug delivery. These devices use pressure to deliver the medication through the skin, which can reduce pain and discomfort during injection. For instance, Portal Instruments’ PRIME autoinjector uses a jet injection technology that can deliver high-viscosity biologics without the need for a needle.
- Disposable Autoinjectors: Disposable autoinjectors are designed to provide a cost-effective and convenient way to administer medication. These devices are designed for single-use and can be easily disposed of after use, reducing the risk of infection and contamination. For instance, Gerresheimer’s Gx InnoSafe autoinjector features a disposable design that can be easily filled and used with a range of drugs.
In conclusion, the autoinjectors market is witnessing significant technological advancements and innovations, driven by the increasing demand for self-administration devices and the need to improve patient outcomes. With the emergence of connected, biologics-compatible, wearable, needle-free, and disposable autoinjectors, the market is poised for significant growth in the future. Manufacturers are investing in R&D to develop advanced autoinjectors that can address the evolving needs of patients and healthcare providers, and drive the adoption of self-administration devices.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.